The medtech compliance landscape looks quite different than it did even two years ago. This year’s Medtech Compliance Workshop is designed around the issues compliance leaders are navigating right now with a focus on how compliance programs operate in practice and where real-world judgment is required. Regulatory expectations around product communications, AI, data privacy, and cross-border operations keep shifting. The questions reaching compliance desks today are harder and don’t often have easy answers.
2026 Is a Defining Year for Medtech Compliance
As industry continues to navigate new challenges, compliance programs continue to evolve to meet the moment with traditional risk areas frequently becoming more complex. While the core rules may be familiar, the operational realities surrounding them are changing, particularly for global organizations managing diverse markets. This year’s Compliance Workshop will explore the issues compliance leaders are encountering today. 2026 agenda topics include:
- Building a Compliance-oriented Organization: Examining how organizations embed compliance into daily operations, overcome resistance, and measure cultural progress in establishing and maintaining ethical decision-making across an organization while the external environment keeps changing.
- Emerging Risks, Enforcement Trends, and Lessons Learned: Analyzing emerging enforcement priorities, including developments under the Anti-Kickback Statute, False Claims Act, and Foreign Corrupt Practices Act, with discussion of practical takeaways.
- Key Compliance Issues: Focused discussions on HCP engagements, grants and sponsorships, reimbursement communications, and managing third-party distributors across global operations.
- Data privacy and AI: Exploring evolving state privacy laws, cross-border data transfer considerations, FDA expectations for AI/ML-enabled technologies, and strategies for building adaptable compliance frameworks amid ongoing regulatory uncertainty.
- External Communications Risks: The latest on compliance considerations for promotional claims, social media, and direct-to-patient communications with evolving modes of communication and changes in the regulatory landscape.
- AdvaMed Policy Priorities: Updates on AdvaMed’s current legal and compliance policy work, including the role of the AdvaMed® Code of Ethics in guiding interactions and supporting broader advocacy efforts.
Who Should Attend
The Medtech Compliance Workshop is for compliance leaders and legal and other professionals responsible for healthcare compliance strategy within medtech organizations. If your role involves navigating complex risk, advising leadership, and building programs that can adapt to an evolving regulatory environment, you can’t miss this event. Space is limited, so register now to join legal and compliance experts in Washington, D.C
Ida Nassar, Esq., Vice President, Assistant General Counsel, Head of Global Ethics & Compliance Policy, AdvaMed®
Hear Patient Stories
The Story of Medtech empowers patients to share their experiences with medical technology in an effort to educate, inspire, and create community.